3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Multiple Myeloma
3
Leukemia, Myeloid, Acute
3
Recurrence
2
Lymphoma, Non-Hodgkin
2
Leukemia, Myelomonocytic, Juvenile
2
Congenital Abnormalities
2
Waldenstrom Macroglobulinemia
1
Thrombocythemia, Essential
1
Sezary Syndrome
1
Sarcoma, Myeloid
1
Primary Myelofibrosis
1
Polycythemia Vera
1
Pdgfra-Associated Chronic Eosinophilic Leukemia
1
Neoplasms, Plasma Cell
1
Neoplasm, Residual
1
Myeloproliferative Disorders
1
Myelodysplastic Syndromes
1
Mycosis Fungoides
1
Mastocytosis
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Lymphoma, Extranodal NK-T-Cell
1
Lymphoma, B-Cell, Marginal Zone
1
Leukemia, Neutrophilic, Chronic
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia, Large Granular Lymphocytic
1
Interventions
Vincristine
13
Temozolomide
12
Cyclophosphamide
11
Irinotecan
8
Magnetic Resonance Spectroscopy
7
X-Rays
6
Vinorelbine
6
Specimen Handling
6
Phantoms, Imaging
6
Dactinomycin
6
Biopsy
5
fludarabine
4
Radiotherapy
4
Radiation
4
Nuclear Medicine Department, Hospital
4
Filgrastim
4
Etoposide
4
pegfilgrastim
3
irinotecan sucrosofate
3
Sirolimus
3
Proton Therapy
3
Melphalan
3
ulixertinib
2
tipifarnib
2
tazemetostat
2
selpercatinib
2
palbociclib
2
olaparib
2
larotrectinib
2
ivosidenib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Rhabdomyosarcoma
×
Transplantation
×
1 year
×
Clear all
No trials found.